IL66611A0 - Pharmaceutical formulations comprising human insulin and human c-peptide - Google Patents

Pharmaceutical formulations comprising human insulin and human c-peptide

Info

Publication number
IL66611A0
IL66611A0 IL66611A IL6661182A IL66611A0 IL 66611 A0 IL66611 A0 IL 66611A0 IL 66611 A IL66611 A IL 66611A IL 6661182 A IL6661182 A IL 6661182A IL 66611 A0 IL66611 A0 IL 66611A0
Authority
IL
Israel
Prior art keywords
human
peptide
pharmaceutical formulations
insulin
human insulin
Prior art date
Application number
IL66611A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL66611A0 publication Critical patent/IL66611A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL66611A 1981-08-27 1982-08-23 Pharmaceutical formulations comprising human insulin and human c-peptide IL66611A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29671581A 1981-08-27 1981-08-27

Publications (1)

Publication Number Publication Date
IL66611A0 true IL66611A0 (en) 1982-12-31

Family

ID=23143238

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66611A IL66611A0 (en) 1981-08-27 1982-08-23 Pharmaceutical formulations comprising human insulin and human c-peptide

Country Status (20)

Country Link
JP (1) JPS5846024A (it)
AU (1) AU551879B2 (it)
BE (1) BE894185A (it)
CA (1) CA1176158A (it)
CH (1) CH650679A5 (it)
DE (1) DE3232034A1 (it)
DZ (1) DZ452A1 (it)
FR (1) FR2513126B1 (it)
GB (1) GB2104382B (it)
IE (1) IE54119B1 (it)
IL (1) IL66611A0 (it)
IT (1) IT1153182B (it)
LU (1) LU84359A1 (it)
MW (1) MW3882A1 (it)
NL (1) NL192192C (it)
NZ (1) NZ201682A (it)
PH (1) PH19361A (it)
SE (1) SE460334B (it)
ZA (1) ZA826159B (it)
ZW (1) ZW17482A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
WO1988002633A1 (en) * 1986-10-20 1988-04-21 Novo Industri A/S Protamine zinc insulin preparations
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
CA1339416C (en) * 1987-02-25 1997-09-02 Liselotte Langkjaer Insulin derivatives
EP0303308B1 (en) * 1987-08-14 1991-05-29 Akzo N.V. Preparation for preventing or combating complications in diabetes
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
SE520392C2 (sv) 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
GB0323979D0 (en) 2003-10-13 2003-11-19 Creative Peptides Sweden Ab Therapeutic applications for c-peptide
WO2006053906A1 (en) * 2004-11-22 2006-05-26 Novo Nordisk A/S Soluble, stable insulin-containing formulations with a protamine salt
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
GB0601950D0 (en) * 2006-01-31 2006-03-15 Creative Peptides Sweden Ab Compositions and methods of treating diabetes
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
KR20130115086A (ko) * 2010-05-17 2013-10-21 세빅스 인코포레이티드 페길화된 c-펩티드
CN104220086A (zh) 2011-11-17 2014-12-17 塞比克斯股份公司 Peg化的c-肽

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit

Also Published As

Publication number Publication date
IT1153182B (it) 1987-01-14
BE894185A (fr) 1983-02-24
IE54119B1 (en) 1989-06-21
DZ452A1 (fr) 2004-09-13
FR2513126A1 (fr) 1983-03-25
IT8223017A0 (it) 1982-08-27
ZA826159B (en) 1984-04-25
NL192192B (nl) 1996-11-01
ZW17482A1 (en) 1982-11-17
PH19361A (en) 1986-04-02
SE460334B (sv) 1989-10-02
NL8203315A (nl) 1983-03-16
GB2104382A (en) 1983-03-09
DE3232034C2 (it) 1991-04-11
NL192192C (nl) 1997-03-04
AU8759482A (en) 1983-03-03
NZ201682A (en) 1985-08-16
MW3882A1 (en) 1984-07-11
DE3232034A1 (de) 1983-03-10
SE8204873L (sv) 1983-02-28
LU84359A1 (fr) 1983-02-28
FR2513126B1 (fr) 1986-04-18
SE8204873D0 (sv) 1982-08-25
AU551879B2 (en) 1986-05-15
JPS5846024A (ja) 1983-03-17
GB2104382B (en) 1984-12-19
CA1176158A (en) 1984-10-16
IE822064L (en) 1983-02-27
CH650679A5 (de) 1985-08-15

Similar Documents

Publication Publication Date Title
GB2105191B (en) Pharmaceutical formulations comprising human insulin and human proinsulin
GB2104382B (en) Pharmaceutical formulations comprising human insulin and human c-peptide
AU549066B2 (en) Preparation of human insulin
GB2106115B (en) Pharmaceutical amides, and preparation, formulations and use thereof
GB2104380B (en) Human proinsulin pharmaceutical formulations
ZW17682A1 (en) Pharmaceutical formulations comprising human insulin human c-peptide and human proinsulin
ZA827001B (en) Pharmaceutical amides,and preparation,formulations and use thereof
JPS57209227A (en) Insulin medicine and manufacture
IE812104L (en) Novel insulin formulations based on human insulin
JO1238B1 (en) Pharmacy formulations include human insulin, human peptide-C and the human insulin component
JO1236B1 (en) Pharmacy formulations that include human insulin and a human-c-peptide
IE822065L (en) Insulin and proinsulin formulations
JO1209B1 (en) Pharmacy formulations that include human insulin and the human insulin component.